A single mutation in Securin induces chromosomal instability and enhances cell invasion

European Journal of Cancer

Volumn 49, Issue 2, 2013, Pages 500-510

  Mora Santos, Mar ^a   Castilla, Carolina ^b   Herrero Ruiz, Joaquín ^a   Giráldez, Servando ^a   Limón Mortés, M Cristina ^a   Sáez, Carmen ^b   Japón, Miguel Á ^b   Tortolero, Maria ^a   Romero, Francisco ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Cell invasiveness; Chromosomal instability; Human mutation; Pituitary tumour; pttg; Securin; Tumourigenesis

Indexed keywords

SECURIN; THREONINE;

ARTICLE; CELL INVASION; CELL MIGRATION; CHROMOSOMAL INSTABILITY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CERCOPITHECUS AETHIOPS; CHROMOSOMAL INSTABILITY; COS CELLS; GENE EXPRESSION; HCT116 CELLS; HELA CELLS; HUMANS; MICROARRAY ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASMS; POINT MUTATION; THREONINE; TRANSFECTION;

EID: 84872115539     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.06.024     Document Type: Article

References (47)

1. T. Hirano, S. Funahashi, T. Uemura, and M. Yanagida Isolation and characterization of Schizosaccharomyces pombe cutmutants that block nuclear division but not cytokinesis EMBO J 5 11 1986 2973 2979
2. A. Yamamoto, V. Guacci, and D. Koshland Pds1p is required for faithful execution of anaphase in the yeast, Saccharomyces cerevisiae J Cell Biol 133 1 1996 85 97
3. A. Yamamoto, V. Guacci, and D. Koshland Pds1p, an inhibitor of anaphase in budding yeast, plays a critical role in the APC and checkpoint pathway(s) J Cell Biol 133 1 1996 99 110
4. H. Zou, T.J. McGarry, T. Bernal, and M.W. Kirschner Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis Science 285 5426 1999 418 422
5. O. Cohen-Fix, J.M. Peters, M.W. Kirschner, and D. Koshland Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p Genes Dev 10 24 1996 3081 3093
6. H. Funabiki, H. Yamano, K. Kumada, K. Nagao, T. Hunt, and M. Yanagida Cut2 proteolysis required for sister-chromatid seperation in fission yeast Nature 381 6581 1996 438 441
7. A. Hagting, N. Den Elzen, H.C. Vodermaier, I.C. Waizenegger, J.M. Peters, and J. Pines Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1 J Cell Biol 157 7 2002 1125 1137
8. F. Romero, A.M. Gil-Bernabe, C. Saez, M.A. Japon, J.A. Pintor-Toro, and M. Tortolero Securin is a target of the UV response pathway in mammalian cells Mol Cell Biol 24 7 2004 2720 2733
9. F. Romero, M.C. Multon, and F. Ramos-Morales Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase Nucleic Acids Res 29 6 2001 1300 1307
10. R.L. Tinker-Kulberg, and D.O. Morgan Pds1 and Esp1 control both anaphase and mitotic exit in normal cells and after DNA damage Genes Dev 13 15 1999 1936 1949
11. A. Dominguez, F. Ramos-Morales, and F. Romero Hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG Oncogene 17 17 1998 2187 2193
12. L. Pei, and S. Melmed Isolation and characterization of a pituitary tumor-transforming gene (PTTG) Mol Endocrinol 11 4 1997 433 441
13. C. Saez, M.A. Japon, and F. Ramos-Morales Hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias Oncogene 18 39 1999 5473 5476
14. C. Saez, M.A. Martinez-Brocca, and C. Castilla Prognostic significance of human pituitary tumor-transforming gene immunohistochemical expression in differentiated thyroid cancer J Clin Endocrinol Metab 91 4 2006 1404 1409
15. C. Saez, T. Pereda, and J.J. Borrero Expression of hpttg proto-oncogene in lymphoid neoplasias Oncogene 21 53 2002 8173 8177
16. X. Zhang, G.A. Horwitz, and A.P. Heaney Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas J Clin Endocrinol Metab 84 2 1999 761 767
17. T. Hamid, M.T. Malik, and S.S. Kakar Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells Mol Cancer 4 1 2005 3
18. A.P. Heaney, R. Singson, C.J. McCabe, V. Nelson, M. Nakashima, and S. Melmed Expression of pituitary-tumour transforming gene in colorectal tumours Lancet 355 9205 2000 716 719
19. C. Solbach, M. Roller, C. Fellbaum, M. Nicoletti, and M. Kaufmann PTTG mRNA expression in primary breast cancer: a prognostic marker for lymph node invasion and tumor recurrence Breast 13 1 2004 80 81
20. L. Pei Identification of c-myc as a down-stream target for pituitary tumor-transforming gene J Biol Chem 276 11 2001 8484 8491
21. H. Ishikawa, A.P. Heaney, R. Yu, G.A. Horwitz, and S. Melmed Human pituitary tumor-transforming gene induces angiogenesis J Clin Endocrinol Metab 86 2 2001 867 874
22. C.J. McCabe, K. Boelaert, and L.A. Tannahill Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors J Clin Endocrinol Metab 87 9 2002 4238 4244
23. X. Zhang, G.A. Horwitz, and T.R. Prezant Structure, expression, and function of human pituitary tumor-transforming gene (PTTG) Mol Endocrinol 13 1 1999 156 166
24. Z. Wang, and S. Melmed Pituitary tumor transforming gene (PTTG) transforming and transactivation activity J Biol Chem 275 11 2000 7459 7461
25. F. Ramos-Morales, A. Dominguez, and F. Romero Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product Oncogene 19 3 2000 403 409
26. K. Boelaert, R. Yu, and L.A. Tannahill PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro J Mol Endocrinol 33 3 2004 663 677
27. A.M. Gil-Bernabe, F. Romero, M.C. Limon-Mortes, and M. Tortolero Protein phosphatase 2A stabilizes human securin, whose phosphorylated forms are degraded via the SCF ubiquitin ligase Mol Cell Biol 26 11 2006 4017 4027
28. M.C. Limon-Mortes, M. Mora-Santos, and A. Espina UV-induced degradation of securin is mediated by SKP1-CUL1-beta TrCP E3 ubiquitin ligase J Cell Sci 121 Pt. 11 2008 1825 1831
29. M. Mora-Santos, M.C. Limon-Mortes, and S. Giraldez Glycogen synthase kinase-3beta (GSK3beta) negatively regulates PTTG1/human securin protein stability, and GSK3beta inactivation correlates with securin accumulation in breast tumors J Biol Chem 286 34 2011 30047 30056
30. F. Romero, A. Germani, and E. Puvion Vav binding to heterogeneous nuclear ribonucleoprotein (hnRNP) C. Evidence for Vav-hnRNP interactions in an RNA-dependent manner J Biol Chem 273 10 1998 5923 5931
31. F. Romero, F. Ramos-Morales, and A. Dominguez Grb2 and its apoptotic isoform Grb3-3 associate with heterogeneous nuclear ribonucleoprotein C, and these interactions are modulated by poly(U) RNA J Biol Chem 273 13 1998 7776 7781
32. P.V. Jallepalli, I.C. Waizenegger, and F. Bunz Securin is required for chromosomal stability in human cells Cell 105 4 2001 445 457
33. Z. Storchova, and C. Kuffer The consequences of tetraploidy and aneuploidy J Cell Sci 121 Pt. 23 2008 3859 3866
34. V.E. Smith, J.A. Franklyn, and C.J. McCabe Pituitary tumor-transforming gene and its binding factor in endocrine cancer Expert Rev Mol Med 12 2010 e38
35. F.F. Zhou, Y. Xue, G.L. Chen, and X. Yao GPS: a novel group-based phosphorylation predicting and scoring method Biochem Biophys Res Commun 325 4 2004 1443 1448
36. L.N. Johnson The regulation of protein phosphorylation Biochem Soc Trans 37 Pt. 4 2009 627 641
37. A. Zur, and M. Brandeis Securin degradation is mediated by fzy and fzr, and is required for complete chromatid separation but not for cytokinesis EMBO J 20 4 2001 792 801
38. L.J. Holt, A.N. Krutchinsky, and D.O. Morgan Positive feedback sharpens the anaphase switch Nature 454 7202 2008 353 357
39. C. Rosse, M. Linch, S. Kermorgant, A.J. Cameron, K. Boeckeler, and P.J. Parker PKC and the control of localized signal dynamics Nat Rev Mol Cell Biol 11 2 2010 103 112
40. V. Cortez, B.C. Nair, D. Chakravarty, and R.K. Vadlamudi Integrin-linked kinase 1: role in hormonal cancer progression Front Biosci (Schol Ed) 3 2011 788 796
41. K. Pfleghaar, S. Heubes, J. Cox, O. Stemmann, and M.R. Speicher Securin is not required for chromosomal stability in human cells PLoS Biol 3 12 2005 2127 2134
42. J.L. Shepard, J.F. Amatruda, and D. Finkelstein A mutation in separase causes genome instability and increased susceptibility to epithelial cancer Genes Dev 21 1 2007 55 59
43. C. Gialeli, A.D. Theocharis, and N.K. Karamanos Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting FEBS J 278 1 2011 16 27
44. N. Makrilia, A. Kollias, L. Manolopoulos, and K. Syrigos Cell adhesion molecules: role and clinical significance in cancer Cancer Invest 27 10 2009 1023 1037
45. M. Tian, J.R. Neil, and W.P. Schiemann Transforming growth factor-beta and the hallmarks of cancer Cell Signal 23 6 2011 951 962
46. J.S. Desgrosellier, and D.A. Cheresh Integrins in cancer: biological implications and therapeutic opportunities Nat Rev Cancer 10 1 2010 9 22
47. R. Sotillo, E. Hernando, and E. Diaz-Rodriguez Mad2 overexpression promotes aneuploidy and tumorigenesis in mice Cancer Cell 11 1 2007 9 23